Heart failure disease management program, its contribution to established pharmacotherapy and long-term prognosis in real clinical practice - retrospective data analysis

Heart failure disease management program, its contribution to established pharmacotherapy and long-term prognosis in real clinical practice - retrospective data analysis

Background and Aims: The prognosis of patients with heart failure (HF) is still generally unfavorable. HF with reduced ejection fraction (HFrEF) patients reach target medication doses in very low percentages in daily clinical practice. HF disease management programs (DMP), including nurse and teleme...

Full description

Bibliographic Details
Main Authors: Marie Lazarova, Dusan Lazar, Filip Malek, Jan Vaclavik, Milos Taborsky, Andrew Ignaszewski
Format: Article
Language:English
Published: Palacký University Olomouc, Faculty of Medicine and Dentistry 2019-12-01
Series:Biomedical Papers
Subjects:
disease management program
heart failure
long term prognosis
pharmacotherapy dose
Online Access:https://biomed.papers.upol.cz/artkey/bio-201904-0005_heart-failure-disease-management-program-its-contribution-to-established-pharmacotherapy-and-long-term-prognos.php

Internet

https://biomed.papers.upol.cz/artkey/bio-201904-0005_heart-failure-disease-management-program-its-contribution-to-established-pharmacotherapy-and-long-term-prognos.php

Similar Items